Publications by authors named "Barkin Berk"

Claim this Profile
L
Lercanidipine Enhances Cisplatin Activity: Dual Anticancer and Anti-Inflammatory Effects via Caspase Activation and MAPK Inhibition.
Tugce Uskur, Sevde Nur Biltekin, Gokhan Faikoglu, Kubra Saygisever-Faikoglu, Barkın Berk

Pharmaceuticals (Basel)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis, antimicrobial activity and modeling studies of thiazoles bearing pyridyl and triazolyl scaffolds.
Naime Funda Tay, Barkın Berk, Murat Duran, İsmail Kayagil, Leyla Yurttaş

Z Naturforsch C J Biosci· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel benzofurane-pyrazole derivatives with anti-inflammatory, cyclooxygenase inhibitory and cytotoxicity evaluation.
Zafer Sahin, Yağmur Özhan, Hande Sipahi, Sevde Nur Biltekin, Leyla Yurttaş, Barkin Berk

Z Naturforsch C J Biosci· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis, characterization, COX1/2 inhibition and molecular modeling studies on novel 2-thio-diarylimidazoles.
Zafer Şahin, Melike Koçoğlu Kalkan, Barkın Berk, Leyla Yurttaş, Ceysu Bender

Turk J Chem· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel cyanothiouracil and cyanothiocytosine derivatives as concentration-dependent selective inhibitors of U87MG glioblastomas: Adenosine receptor binding and potent PDE4 inhibition.
Zafer Sahin, Sevde Nur Biltekin, Leyla Yurttas, Barkin Berk, Yağmur Özhan

Eur J Med Chem· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Significance of Tumor Tissue NeuGcGM3 Ganglioside Expression in Patients Receiving Racotumomab Immunotherapy.
Necdet Uskent, Sule Ayla, Nil Molinas Mandel, Metin Ozkan, Mehmet Teomete, Barkın Berk

J Oncol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potent ribonucleotide reductase inhibitors: Thiazole-containing thiosemicarbazone derivatives.
Merve Ertas, Zafer Sahin, Emre F Bulbul, Ceysu Bender, Sevde N Biltekin, Barkin Berk

Arch Pharm (Weinheim)· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thiazole-substituted benzoylpiperazine derivatives as acetylcholinesterase inhibitors.
Zafer Sahin, Merve Ertas, Ceysu Bender, Emre F Bülbül, Barkin Berk

Drug Dev Res· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Studies on non-steroidal inhibitors of aromatase enzyme; 4-(aryl/heteroaryl)-2-(pyrimidin-2-yl)thiazole derivatives.
Zafer Sahin, Merve Ertas, Barkın Berk, Sevde Nur Biltekin, Leyla Yurttas

Bioorg Med Chem· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pyridine-substituted thiazolylphenol derivatives: Synthesis, modeling studies, aromatase inhibition, and antiproliferative activity evaluation.
Merve Ertas, Zafer Sahin, Barkin Berk, Leyla Yurttas, Sevde N Biltekin

Arch Pharm (Weinheim)· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and antimycobacterial activity of some phthalimide derivatives.
Hülya Akgün, Irem Karamelekoğlu, Barkın Berk, Işıl Kurnaz, Gizem Sarıbıyık

Bioorg Med Chem· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In silico analysis of the binding of agonists and blockers to the β2-adrenergic receptor.
Santiago Vilar, Joel Karpiak, Barkin Berk, Stefano Costanzi

J Mol Graph Model· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Docking-based virtual screening for ligands of G protein-coupled receptors: not only crystal structures but also in silico models.
Santiago Vilar, Giulio Ferino, Sharangdhar S Phatak, Barkin Berk, Claudio N Cavasotto

J Mol Graph Model· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pyrimidine ribonucleotides with enhanced selectivity as P2Y(6) receptor agonists: novel 4-alkyloxyimino, (S)-methanocarba, and 5'-triphosphate gamma-ester modifications.
Hiroshi Maruoka, Matthew O Barrett, Hyojin Ko, Dilip K Tosh, Artem Melman, Barkin Berk

J Med Chem· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and synthesis of some (S)-2-(6-methoxynaphthalen-2-yl)-N-substituted ethyl propanamide derivatives as potent non-ulcerogenic anti-inflammatory and analgesic agents.
Barkin Berk, Dilek Demir Erol, Esra Kupeli, Erdem Yesilada

Arzneimittelforschung· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New 8-substituted xanthiene derivatives as potent bronchodilators.
Barkin Berk, Hülya Akgün, Kevser Erol, Başar Sirmagül, Zhan-Guo Gao

Farmaco· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis